Oct 1 (Reuters) - Stellar Biotechnologies Inc KLH.V :
* Stellar Biotechnologies and amaran biotechnology provide update on
collaboration
* Says obi pharma expects obi-822 topline results to be announced by March,
2016
* Says to support obi pharma's planned global phase III trial and potential
future market launch
* Source text for Eikon ID:nMKWBfYWla
* Further company coverage KLH.V